Clinician Insights on How to Manage Semaglutide-Induced Gastroparesis: Part II
Beyond performing a differential diagnosis, how can clinicians manage gastroparesis that results from a GLP-1 receptor agonist like semaglutide?
Beyond performing a differential diagnosis, how can clinicians manage gastroparesis that results from a GLP-1 receptor agonist like semaglutide?
Female cardiologists from across the country share their perspectives on why cardiovascular disease is still the leading cause of death for women in the US.
In an interview, Jeffrey S Berger, MD, shares his thoughts on updated USPSTF guidelines that address risk of major bleeding from aspirin use for primary prevention of CVD.